Impact of a School-Based Nutrition Intervention in Preventing Overweight and Obesity in Children in Thailand.


Journal

The Journal of school health
ISSN: 1746-1561
Titre abrégé: J Sch Health
Pays: United States
ID NLM: 0376370

Informations de publication

Date de publication:
02 2023
Historique:
revised: 03 08 2022
received: 21 04 2022
accepted: 15 09 2022
pubmed: 12 10 2022
medline: 24 1 2023
entrez: 11 10 2022
Statut: ppublish

Résumé

This study evaluated the impact of a school-based nutrition program on preventing overweight and obesity in children in Thailand from 2014 to 2019. We used difference-in-differences with matched comparison group to evaluate program impact. Treatment schools were categorized into those that participated in phase 1 only, and those that participated in phase 1 and 2. We matched 311 treatment schools in phase 1 only with 1504 comparison schools, and 75 treatment schools in both phases with 216 comparison schools. Administrative data from Thailand Office of Basic Education Commission were used from 2014 (baseline), 2016 (first follow-up), and 2019 (second follow-up). Program resulted in a 0.6-1.1 percentage point reduction in the students' probability of overweight by the end of phase 1, and 1.7 percentage points by the end of phase 2. Impact on obesity was found only for schools participating in both phases (0.4 and 0.9 percentage points by the end of phase 1 and 2, respectively). Program continuity and intensity are key to achieve a reduction in overweight and obesity in schoolchildren. The program was successful in reducing overweight and/or obesity given appropriate level of continuity and intensity.

Sections du résumé

BACKGROUND
This study evaluated the impact of a school-based nutrition program on preventing overweight and obesity in children in Thailand from 2014 to 2019.
METHODS
We used difference-in-differences with matched comparison group to evaluate program impact. Treatment schools were categorized into those that participated in phase 1 only, and those that participated in phase 1 and 2. We matched 311 treatment schools in phase 1 only with 1504 comparison schools, and 75 treatment schools in both phases with 216 comparison schools. Administrative data from Thailand Office of Basic Education Commission were used from 2014 (baseline), 2016 (first follow-up), and 2019 (second follow-up).
RESULTS
Program resulted in a 0.6-1.1 percentage point reduction in the students' probability of overweight by the end of phase 1, and 1.7 percentage points by the end of phase 2. Impact on obesity was found only for schools participating in both phases (0.4 and 0.9 percentage points by the end of phase 1 and 2, respectively).
IMPLICATIONS FOR SCHOOL HEALTH POLICY, PRACTICE, AND EQUITY
Program continuity and intensity are key to achieve a reduction in overweight and obesity in schoolchildren.
CONCLUSIONS
The program was successful in reducing overweight and/or obesity given appropriate level of continuity and intensity.

Identifiants

pubmed: 36217922
doi: 10.1111/josh.13253
pmc: PMC10092697
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

140-147

Subventions

Organisme : NICHD NIH HHS
ID : P2C HD050924
Pays : United States

Informations de copyright

© 2022 The Authors. Journal of School Health published by Wiley Periodicals LLC on behalf of American School Health Association.

Références

Cochrane Database Syst Rev. 2019 Jul 23;7:CD001871
pubmed: 31332776
Obes Res Clin Pract. 2014 Sep-Oct;8(5):e497-510
pubmed: 25263839
Am J Prev Med. 2009 Nov;37(5):418-27
pubmed: 19840696
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD001871
pubmed: 22161367
Rev Epidemiol Sante Publique. 2015 Jun;63(3):173-82
pubmed: 26002984
J Clin Endocrinol Metab. 2003 Apr;88(4):1417-27
pubmed: 12679416
Int J Pediatr Obes. 2010 Aug;5(4):282-304
pubmed: 20210677
Int J Obes (Lond). 2013 Jan;37(1):79-85
pubmed: 22945605
J Sch Health. 2023 Feb;93(2):140-147
pubmed: 36217922
Pediatrics. 2007 Dec;120 Suppl 4:S164-92
pubmed: 18055651
PLoS One. 2018 Sep 27;13(9):e0204560
pubmed: 30261057
Obes Rev. 2011 Feb;12(2):131-41
pubmed: 20122135
Lancet Diabetes Endocrinol. 2018 Apr;6(4):332-346
pubmed: 29066096
JAMA Pediatr. 2016 Mar;170(3):220-6
pubmed: 26784336
PLoS One. 2013;8(2):e57498
pubmed: 23451237
J Allergy Clin Immunol. 2005 May;115(5):897-909; quiz 910
pubmed: 15867841
Int J Obes (Lond). 2014 Oct;38(10):1263-7
pubmed: 25002148
Obes Rev. 2012 Mar;13(3):214-33
pubmed: 22070186
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830

Auteurs

Manasigan Kanchanachitra (M)

Institute for Population and Social Research, Mahidol University, 999 Phuttamonthon Sai 4, Salaya, Phuttamonthon, Nakhon Pathom, 73170, Thailand.

Gustavo Angeles (G)

Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 400 Meadowmont Circle, Chapel Hill, NC, 27599.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH